Patents by Inventor Michael Leane

Michael Leane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical treatment process using chitosan or derivative thereof
    Patent number: 8709996
    Abstract: The present invention provides a solid composition for oral administration comprising: (i) a drug compound; (ii) chitosan or a derivative thereof or a salt of chitosan or salt of a derivative of chitosan; and (iii) an organic acid. Preferably the drug compound is a polar molecule having a molecular weight of 1 KDa or less, a peptide, a protein or a polysaccharide. The compositions of the invention provide enhance absorption of the drug compound.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: April 29, 2014
    Assignee: Archimedes Development Limited
    Inventors: Michael Leane, Alan Smith, Lisbeth Illum
  • PHARMACEUTICAL TREATMENT PROCESS USING CHITOSAN OR DERIVATIVE THEREOF
    Publication number: 20100203119
    Abstract: The present invention provides a solid composition for oral administration comprising: (i) a drug compound; (ii) chitosan or a derivative thereof or a salt of chitosan or salt of a derivative of chitosan; and (iii) an organic acid. Preferably the drug compound is a polar molecule having a molecular weight of 1 KDa or less, a peptide, a protein or a polysaccharide. The compositions of the invention provide enhance absorption of the drug compound.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: ARCHIMEDES DEVELOPMENT LIMITED
    Inventors: Michael LEANE, Alan SMITH, Lisbeth ILLUM
  • Pharmaceutical compositions
    Publication number: 20060115525
    Abstract: The present invention provides a solid composition for oral administration comprising: (i) a drug compound; (ii) chitosan or a derivative thereof or a salt of chitosan or salt of a derivative of chitosan; and (iii) an organic acid. Preferably the drug compound is a polar molecule having a molecular weight of 1 KDa or less, a peptide, a protein or a polysaccharide. The compositions of the invention provide enhance absorption of the drug compound.
    Type: Application
    Filed: November 12, 2005
    Publication date: June 1, 2006
    Inventors: Michael Leane, Alan Smith, Lisbeth Illum